AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01798901
Recruitment Status : Completed
First Posted : February 26, 2013
Last Update Posted : March 14, 2018
Information provided by (Responsible Party):
Alison Walker, Ohio State University Comprehensive Cancer Center